{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:10:08Z","timestamp":1784772608110,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005013","name":"Academic Center for Education, Culture and Research","doi-asserted-by":"publisher","award":["[ACECR 3101-20]"],"award-info":[{"award-number":["[ACECR 3101-20]"]}],"id":[{"id":"10.13039\/501100005013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s13365-023-01176-6","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T14:03:22Z","timestamp":1698069802000},"page":"35-40","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Immune response to COVID-19 vaccines among people living with human T-cell lymphotropic virus type 1 infection: a retrospective cohort study from Iran"],"prefix":"10.1007","volume":"31","author":[{"given":"Reza","family":"Jafarzadeh Esfehani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohreh","family":"Vahidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Shariati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arman","family":"Mosavat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azam","family":"Shafaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Shahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houshang","family":"Rafatpanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid Reza","family":"Bidkhori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Boostani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9133-5006","authenticated-orcid":false,"given":"Mohammad Reza","family":"Hedayati-Moghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,23]]},"reference":[{"key":"1176_CR1","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3390\/pathogens9060438","volume":"9","author":"A Araujo","year":"2020","unstructured":"Araujo A, Martin F (2020) Human T leukaemia Type 1 and COVID-19. Pathogens 9:438","journal-title":"Pathogens"},{"key":"1176_CR2","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1136\/sextrans-2021-055007","volume":"98","author":"A Araujo","year":"2022","unstructured":"Araujo A, Martin F (2022) SARS-CoV-2 vaccination of people living with human T leukaemia virus type 1. Sex Transm Infect 98:154","journal-title":"Sex Transm Infect"},{"key":"1176_CR3","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1016\/j.chom.2021.11.004","volume":"29","author":"NJ Dashdorj","year":"2021","unstructured":"Dashdorj NJ, Wirz OF, Roltgen K, Haraguchi E, Buzzanco AS 3rd, Sibai M, Wang H, Miller JA, Solis D, Sahoo MK, Arunachalam PS, Lee AS, Shah MM, Liu J, Byambabaatar S, Bat-Ulzii P, Enkhbat A, Batbold E, Zulkhuu D, Ochirsum B, Khurelsukh T, Dalantai G, Burged N, Baatarsuren U, Ariungerel N, Oidovsambuu O, Bungert AS, Genden Z, Yagaanbuyant D, Mordorj A, Pulendran B, Chinthrajah S, Nadeau KC, Jardetzky T, Wilbur JL, Wohlstadter JN, Sigal GB, Pinsky BA, Boyd SD, Dashdorj ND (2021) Direct comparison of antibody responses to four SARS-CoV-2 vaccines in Mongolia. Cell Host Microbe 29:1738\u20131743","journal-title":"Cell Host Microbe"},{"key":"1176_CR4","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3390\/vaccines9091028","volume":"9","author":"Y Fu","year":"2021","unstructured":"Fu Y, Chen F, Cui L, Zhao Y, Zhang H, Fu S, Zhang J (2021) Immunological analysis of people in Northeast China after SARS-CoV-2 inactivated vaccine injection. Vaccines 9:1028","journal-title":"Vaccines"},{"key":"1176_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v10010001","volume":"10","author":"N Futsch","year":"2017","unstructured":"Futsch N, Mahieux R, Dutartre H (2017) HTLV-1, the other pathogenic yet neglected human retrovirus: from transmission to therapeutic treatment. Viruses 10:1","journal-title":"Viruses"},{"key":"1176_CR6","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1128\/CMR.00063-09","volume":"23","author":"DU Gon\u00e7alves","year":"2010","unstructured":"Gon\u00e7alves DU, Proietti FA, Ribas JGR, Ara\u00fajo MG, Pinheiro SR, Guedes AC, Carneiro-Proietti ABF (2010) Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases. Clin Microbiol Rev 23:577\u2013589","journal-title":"Clin Microbiol Rev"},{"key":"1176_CR7","doi-asserted-by":"publisher","first-page":"1073259","DOI":"10.3389\/fpubh.2023.1073259","volume":"11","author":"MM Gouya","year":"2023","unstructured":"Gouya MM, Seif-Farahi K, Hemmati P (2023) An overview of Iran\u2019s actions in response to the COVID-19 pandemic and in building health system resilience. Front Public Health 11:1073259","journal-title":"Front Public Health"},{"key":"1176_CR8","doi-asserted-by":"publisher","DOI":"10.1017\/dmp.2022.45","volume":"17","author":"M Heidari","year":"2022","unstructured":"Heidari M, Sayfouri N, Jafari H (2022) Consecutive Waves of COVID-19 in Iran: Various Dimensions and Probable Causes. Disaster Med Public Health Prep 17:e136","journal-title":"Disaster Med Public Health Prep"},{"key":"1176_CR9","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/ajh.26284","volume":"96","author":"K Herzog Tzarfati","year":"2021","unstructured":"Herzog Tzarfati K, Gutwein O, Apel A, Rahimi-Levene N, Sadovnik M, Harel L, Benveniste-Levkovitz P, Bar Chaim A, Koren-Michowitz M (2021) BNT162b2 COVID-19 vaccine is significantly less effective in patients with hematologic malignancies. Am J Hematol 96:1195\u20131203","journal-title":"Am J Hematol"},{"key":"1176_CR10","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1016\/S1473-3099(20)30328-5","volume":"21","author":"A Hirons","year":"2021","unstructured":"Hirons A, Khoury G, Purcell DF (2021) Human T-cell lymphotropic virus type-1: A lifelong persistent infection, yet never truly silent. Lancet Infect Dis 21:e2\u2013e10","journal-title":"Lancet Infect Dis"},{"key":"1176_CR11","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/nep.13980","volume":"27","author":"SG Holt","year":"2022","unstructured":"Holt SG, Mahmoud S, Ahmed W, Acuna JM, Al Madani AK, Eltantawy I, Zaher WA, Goodier GJ, Al Kaabi NA, Al Obaidli AA (2022) An analysis of antibody responses and clinical sequalae of the Sinopharm HB02 COVID19 vaccine in dialysis patients in the United Arab Emirates. Nephrology (carlton) 27:260\u2013268","journal-title":"Nephrology (carlton)"},{"key":"1176_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1515\/bmc-2018-0007","volume":"9","author":"G Kak","year":"2018","unstructured":"Kak G, Raza M, Tiwari BK (2018) Interferon-gamma (IFN-\u03b3): Exploring its implications in infectious diseases. Biomol Concepts 9:64\u201379","journal-title":"Biomol Concepts"},{"key":"1176_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/molecules26010039","volume":"26","author":"M Khan","year":"2020","unstructured":"Khan M, Adil SF, Alkhathlan HZ, Tahir MN, Saif S, Khan M, Khan ST (2020) COVID-19: a global challenge with old history, epidemiology and progress so far. Molecules 26:39","journal-title":"Molecules"},{"key":"1176_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-068632","volume":"376","author":"A Lee","year":"2022","unstructured":"Lee A, Wong SY, Chai LYA, Lee SC, Lee MX, Muthiah MD, Tay SH, Teo CB, Tan BKJ, Chan YH, Sundar R, Soon YY (2022) Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis. BMJ 376:e068632","journal-title":"BMJ"},{"key":"1176_CR15","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.3390\/vaccines9091031","volume":"9","author":"O Lijeski\u0107","year":"2021","unstructured":"Lijeski\u0107 O, Klun I, Stamenov Djakovi\u0107 M, Gligori\u0107 N, \u0160tajner T, Srbljanovi\u0107 J, Djurkovi\u0107-Djakovi\u0107 O (2021) Prospective cohort study of the kinetics of specific antibodies to SARS-CoV-2 infection and to four SARS-CoV-2 vaccines available in Serbia, and vaccine effectiveness: a 3-month interim report. Vaccines 9:1031","journal-title":"Vaccines"},{"key":"1176_CR16","doi-asserted-by":"publisher","first-page":"e568","DOI":"10.1016\/S2352-3018(21)00157-0","volume":"8","author":"SA Madhi","year":"2021","unstructured":"Madhi SA, Koen AL, Izu A, Fairlie L, Cutland CL, Baillie V, Padayachee SD, Dheda K, Barnabas SL, Bhorat QE (2021) Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B\/2A trial. The Lancet HIV 8:e568\u2013e580","journal-title":"The Lancet HIV"},{"key":"1176_CR17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","volume":"23","author":"P Moss","year":"2022","unstructured":"Moss P (2022) The T cell immune response against SARS-CoV-2. Nat Immunol 23:186\u2013193","journal-title":"Nat Immunol"},{"key":"1176_CR18","doi-asserted-by":"crossref","unstructured":"Paludan SR, Mogensen TH (2022) Innate immunological pathways in COVID-19 pathogenesis. Sci Immunol 7:eabm5505","DOI":"10.1126\/sciimmunol.abm5505"},{"key":"1176_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/v8010005","volume":"8","author":"JA Quaresma","year":"2015","unstructured":"Quaresma JA, Yoshikawa GT, Koyama RV, Dias GA, Fujihara S, Fuzii HT (2015) HTLV-1, immune response and autoimmunity. Viruses 8:5","journal-title":"Viruses"},{"key":"1176_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2022.146550","volume":"834","author":"S Sajjadi","year":"2022","unstructured":"Sajjadi S, Hejazi S, Ravanshad S, Jafarzadeh Esfehani R (2022) Human T-lymphotropic virus type 1 and novel coronavirus disease 2019; More complex than just a simple coinfection. Gene 834:146550","journal-title":"Gene"},{"key":"1176_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S1473-3099(19)30402-5","volume":"20","author":"G Schierhout","year":"2020","unstructured":"Schierhout G, McGregor S, Gessain A, Einsiedel L, Martinello M, Kaldor J (2020) Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studies. Lancet Infect Dis 20:133\u2013143","journal-title":"Lancet Infect Dis"},{"key":"1176_CR22","doi-asserted-by":"publisher","first-page":"6283","DOI":"10.1038\/s41598-021-85359-3","volume":"11","author":"P Ssentongo","year":"2021","unstructured":"Ssentongo P, Heilbrunn ES, Ssentongo AE, Advani S, Chinchilli VM, Nunez JJ, Du P (2021) Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis. Sci Rep 11:6283","journal-title":"Sci Rep"},{"key":"1176_CR23","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.37069","volume":"4","author":"JM Tesoriero","year":"2021","unstructured":"Tesoriero JM, Swain CE, Pierce JL, Zamboni L, Wu M, Holtgrave DR, Gonzalez CJ, Udo T, Morne JE, Hart-Malloy R (2021) COVID-19 outcomes among persons living with or without diagnosed HIV infection in New York State. JAMA Netw Open 4:e2037069","journal-title":"JAMA Netw Open"},{"key":"1176_CR24","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.3390\/ijms22052723","volume":"22","author":"L Tian","year":"2021","unstructured":"Tian L, Elsheikh EB, Patrone PN, Kearsley AJ, Gaigalas AK, Inwood S, Lin-Gibson S, Esposito D, Wang L (2021) Towards quantitative and standardized serological and neutralization assays for COVID-19. Int J Mol Sci 22:2723","journal-title":"Int J Mol Sci"},{"key":"1176_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.antiviral.2016.10.015","volume":"137","author":"L Willems","year":"2017","unstructured":"Willems L, Hasegawa H, Accolla R, Bangham C, Bazarbachi A, Bertazzoni U, de Freitas Carneiro-Proietti AB, Cheng H, Chieco-Bianchi L, Ciminale V (2017) Reducing the global burden of HTLV-1 infection: an agenda for research and action. Antiviral Res 137:41\u201348","journal-title":"Antiviral Res"},{"key":"1176_CR26","unstructured":"World Health Organization (2023) Available from: https:\/\/covid19.who.int\/region\/emro\/country\/ir. Accessed 27 Aug 2023"},{"key":"1176_CR27","doi-asserted-by":"publisher","first-page":"e2123622","DOI":"10.1001\/jamanetworkopen.2021.23622","volume":"4","author":"K Yau","year":"2021","unstructured":"Yau K, Abe KT, Naimark D, Oliver MJ, Perl J, Leis JA, Bolotin S, Tran V, Mullin SI, Shadowitz E (2021) Evaluation of the SARS-CoV-2 antibody response to the BNT162b2 vaccine in patients undergoing hemodialysis. JAMA Netw Open 4:e2123622\u2013e2123622","journal-title":"JAMA Netw Open"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-023-01176-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13365-023-01176-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-023-01176-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T21:22:47Z","timestamp":1743888167000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13365-023-01176-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,23]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1176"],"URL":"https:\/\/doi.org\/10.1007\/s13365-023-01176-6","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"value":"1355-0284","type":"print"},{"value":"1538-2443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,23]]},"assertion":[{"value":"19 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}